Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 346-355

  Borutinskaite, Veronika V ^a,b   Navakauskiene, Ruta ^a   Magnusson, Karl Eric ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Histone deacetylase inhibitor; p21; p53; Proliferation

Indexed keywords

BML 210; HISTONE DEACETYLASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; RETINOIC ACID; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ANILIDE; GROWTH INHIBITOR; HISTONE DEACETYLASE; N1 (2 AMINOPHENYL) N8 PHENYLOCTANEDIAMIDE; N1-(2-AMINOPHENYL)-N8-PHENYLOCTANEDIAMIDE;

APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UTERINE CERVIX CANCER; ARTICLE; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18;

ANILIDES; CELL PROLIFERATION; FEMALE; GROWTH INHIBITORS; HELA CELLS; HISTONE DEACETYLASES; HUMANS; TRETINOIN; UTERINE CERVICAL NEOPLASMS;

EID: 33947578115     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.079     Document Type: Conference Paper

References (23)

1. HAWLEY-NELSON, P. et al. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8: 3905-3910.
2. HUDSON, J.B. et al. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64: 519-526.
3. MUNGER, K. et al. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8: 4099-4105.
4. MIETS, I.A. et al. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11: 5013-5020.
5. XIONG, Y. et al. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
6. SCEFFNER, M. et al. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
7. GUDAS, L.J. 1994. Retinoids and vertebrate development. J. Biol. Chem. 269: 15399-15402.
8. NILES, R.M. 2000. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 16: 1084-1089.
9. NICHOLSON, R.C. et al. 1990. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J. 9: 4443-4454.
10. SCHULE, R. et al. 1991. Retinoic acid is a negative regulator of AP-1- responsive genes. Proc. Natl. Acad. Sci. USA 88: 6092-6096.
11. STRAHL, B.D. & C.D. ALLIS. 2000. The language of covalent histone modifications. Nature (Lond.) 403: 41-45.
12. TRISCIUOGLIO, D. et al. 2004. bcl-2 Induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation. J. Biol. Chem. 279: 6737-6745.
13. DENG, G. & E.R. PODACK. 1993. Suppression of apoptosis in a cytotoxic T-Cell line by interleukin 2- mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl. Acad. Sci. USA 90: 2189-2193.
14. KORSMEYER, S.J. 1992. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-886.
15. NUNEZ, G. et al. 1990. Bcl-2 maintains B cell memory. Nature 353: 71-73.
16. DUAN, H. et al. 2005. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell. Biol. 25: 1608-1619.
17. UM, S.J. et al. 2000. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. Int. J. Cancer 85: 416-423.
18. SANCHEZ-PRIETO, R. et al. 2000. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60: 2464-2472.
19. BEARDMORE, V.A. et al. 2005. Generation and characterization of p38β (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25: 10454-10464.
20. BIGGS, J.R. et al. 1996. The role of transcriptional factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271: 901-906.
21. LIU, M. et al. 1996. Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor. J. Biol. Chem. 271: 31723-31728.
22. KAVURMA, M.M. & L.M. KHACHIGIAN. 2003. ERK, JNK, and p38MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. J. Biol. Chem. 278: 32537-32543.
23. CHOU, H.K. 2000. Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells. Biochem. J. 348: 473-479.